Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity Jan. 2, 1998 No Comments
Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor Dec. 30, 1997 No Comments
RSS